Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397)
03/2010
03/30/2010US7687502 Substituted quinazoline or pyridopyrimidine derivative
03/30/2010US7687500 Substituted oxetanes, method of making, and method of use thereof
03/30/2010US7687498 N-(Arylidene)morpholinylpyridinylhydrazine derivatives, e.g., N-{4-[2-(3,4-Dimethoxy-phenyl)-ethoxy]-6-morpholin-4-yl-pyridin-2-yl}-N'-(3-methyl-benzylidene)-hydrazine, are used for treating interleukin-12 overproduction-related disorders including inflammatory diseases
03/30/2010CA2577525C Inhibitors of hepatitis c virus rna-dependent rna polymerase, and compositions and treatments using the same
03/30/2010CA2457444C 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity
03/30/2010CA2436667C Novel bioactive substance
03/30/2010CA2389306C Aryl- and heteroaryl-substituted tetrahydroisoquinolines and use thereof to block reuptake of norepinephrine, dopamine and serotonin
03/30/2010CA2360685C Methods for restoring and/or enhancing accommodation in pseudo phakia
03/30/2010CA2306429C Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors
03/25/2010WO2010033543A2 Novel compounds as cannabinoid receptor ligands
03/25/2010WO2010032856A1 Nitrogen-containing heterocyclic compound and use of same
03/25/2010WO2010032771A1 Amino acid derivative
03/25/2010WO2010032225A2 Process for preparation of darifenacin and intermediates used in the process
03/25/2010WO2010032200A1 Amide compounds useful in therapy
03/25/2010WO2010031713A1 Substituted pyrrolidine-2-carboxamides
03/25/2010WO2009111998A3 Specific impurities of montelukast
03/25/2010US20100076200 Purification of olmesartan medoxomil
03/25/2010US20100076188 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome
03/25/2010US20100076051 Isoindolinone kinase inhibitors
03/25/2010US20100075988 Tetrahydroquinazoline compounds and their use in preparing medicaments for treating and preventing virosis
03/25/2010US20100075971 Substituted pyridine derivatives useful in the treatment of cancer and other disorders
03/25/2010US20100075967 Pyrimidine derivatives for treatment of hyperproliferative disorders
03/25/2010US20100075953 Substituted piperazines, (1,4) diazepines, and 2,5-diazabicyclo (2.2.1) heptanes as histamine h1 and/or h3 antagonists or histamine h3 reverse antagonists
03/25/2010US20100075941 Preventive/remedy for retinal nerve diseases containing alkyl ether derivatives or salts thereof
03/25/2010US20100075924 Dutpase inhibitors
03/25/2010CA2770302A1 Small molecule compounds for stem cell differentiation
03/25/2010CA2737431A1 Amino acid derivative
03/25/2010CA2737199A1 Novel compounds as cannabinoid receptor ligands
03/25/2010CA2735931A1 Amide compounds useful in therapy
03/25/2010CA2734363A1 Substituted pyrrolidine-2-carboxamides
03/24/2010EP2165709A2 Lysine based compounds
03/24/2010EP2165708A2 New pyrazole derivatives as transforming growth factor (tgf) inhibitors
03/24/2010EP2164845A1 Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
03/24/2010EP2164843A1 Pyridazinone derivates
03/24/2010EP2164840A2 Modulators of cftr
03/24/2010EP2164833A2 Quinazolinamide derivatives
03/24/2010EP2164326A1 Amide compounds and the use thereof
03/24/2010EP1902036B1 Process for the preparation of rosuvastatin and intermediates
03/24/2010EP1644357B9 Trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
03/24/2010EP1389110B1 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same
03/24/2010CN101679391A Improved synthesis of (2s-cis)-2-(bromomethyl)-2-(4-chlorophenyl)-1,3 dioxolane-4-methanol methanesulfonate(ester)
03/24/2010CN101679390A Ground crystal of olmesartan medoxomil
03/24/2010CN101679389A co-crystals of propiconazole
03/24/2010CN101679388A Novel 4-heteroaryl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
03/24/2010CN101679377A Heterocyclic hydrazide compound and pesticidal use of the same
03/24/2010CN101679376A fungicide heterocyclyl-pyrimidinyl-amino derivatives
03/24/2010CN101679375A 8-oxy-quinoline derivatives as bradykinin b2 receptor modulators
03/24/2010CN101679371A Substituted pyrimidines as adenosine receptor antagonists
03/24/2010CN101679364A heteroarylamide pyrimidone compounds
03/24/2010CN101679361A Certain substituted amides, method of making, and method of use thereof
03/24/2010CN101679358A Pyrrole derivatives as p2y12 antagonists
03/24/2010CN101679357A Substituted heterocyclic derivatives and their pharmaceutical use and compositions
03/24/2010CN101679354A Novel triazinedione derivatives as GABAB receptor modulators
03/24/2010CN101679319A Triazole compounds that modulate hsp90 activity
03/24/2010CN101679318A Development of molecular imaging probes for carbonic anhydrase-IX using click chemistry
03/24/2010CN101679296A Novel 4-phenyl-imidazole-2-thiones used as tyrosinase inhibitors, method for preparing same and use thereof in human medicine and cosmetology
03/24/2010CN101679270A dihydroquinone and dihydronaphthridine inhibitors of jnk
03/24/2010CN101679264A inhibitors of focal adhesion kinase
03/24/2010CN101679262A Pyridone compound
03/24/2010CN101679261A Piperazine and piperidine mglur5 potentiators
03/24/2010CN101679247A Process for the manufacture for non-steroidal anti-inflammatory agents and intermediates thereof
03/24/2010CN101679245A 3-(2-alkoxy-phenyl)-substituted tetramates
03/24/2010CN101679239A inhibitors of histone deacetylase
03/24/2010CN101679235A Azetidine derivatives and their use as prostaglandin E2 antagonists
03/24/2010CN101678215A Sulfonyl amide derivatives for the treatment of abnormal cell growth
03/24/2010CN101678129A Radioactive pet agents for imaging CCR5 in vivo
03/24/2010CN101678020A Quinoxaline derivatives as inhibitors of the tyrosine kinase activity of Janus kinases
03/24/2010CN101676271A Tetracycline derivatives containing unsaturated heterocyclic amine
03/24/2010CN101676268A frangible compounds for pathogen inactivation
03/24/2010CN101676264A Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-IV (DPP-IV)
03/24/2010CN100595195C Preparation method and application of isoquinoline componds and salts thereof
03/23/2010US7683173 Biphenyl compounds useful as muscarinic receptor antagonists
03/23/2010US7683094 2-(2-((2R)-2-heptylaminomethyl-5-oxopyrrolidin-1-yl)ethylthio)-1,3-thiazole-4-carboxylic acid; EP2 and/or EP4 receptor agonist; immune disease; antiallergens; alopecia; dysmenorrhea; erectile dysfuncction; antiarthritic agents; liver, respiratory, vascular, urogenital disorder
03/23/2010US7683070 insecticides for soil-borne insects, such as termites and white grubs; less costly and safer to use on crops; N-{4-[(4-{bis[4-(trifluoromethyl)phenyl]methylene}piperidyl)methyl]phenyl}ethoxycarboxamide, N-oxide
03/23/2010US7683068 Emesis, urinary incontinence, depression, and anxiety; substance P inhibitors; 5-{1-[3,5-bis(Trifluoromethyl)phenyl]ethoxy}-4-(4-fluorophenyl)octahydro-1H-isoindole
03/23/2010US7683067 3-heterocyclyl-indole derivatives as inhibitors of glycogen synthase kinase-3 (GSK-3)
03/23/2010US7683063 inhibiting Vanilloid Receptor 1; Inflammatory bowel disease; Crohn's disease and ulcerative colitis; cyclo(hetero)alkenyl compound
03/23/2010US7683059 Triazole compounds and uses related thereto
03/23/2010CA2471729C Prucalopride-n-oxide
03/23/2010CA2405972C Process for the preparation of aniline compounds
03/23/2010CA2397594C Ethanol solvate of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8[4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
03/23/2010CA2354387C Substituted pyridine herbicides
03/18/2010WO2010030967A1 4-aryloxyquinolin-2(1h)-ones as mtor kinase and pi3 kinase inhibitors, for use as anti-cancer agents
03/18/2010WO2010030592A1 Compounds for the treatment of hepatitis c
03/18/2010WO2010030224A1 A process for preparing [1s- [1-alpha, 2-alpha, 3-beta (1s*, 2r*) 5-beta] ] -3- [7- [2- (3, 4-dif luorophenyl) -cyclopropylamino] - 5- (propylthio) -3h-1, 2, 3-triazolo [4, 5-d] pyrimidin-3-yl] -5- (2- hydroxyethoxy) cyclopentane-1, 2-diol and to its intermediates
03/18/2010WO2010030027A1 Aromatic nitrogen-containing 6-membered ring compounds and their use
03/18/2010WO2010029925A1 Novel prostaglandin i<sb>2</sb> derivative
03/18/2010WO2010029561A1 A process for preparation of rosuvastatin acetonide calcium
03/18/2010WO2010029299A1 Pyrimidinone derivaties for use as medicaments
03/18/2010WO2010028776A1 Piperazine derivatives for binding and imaging amyloid plaques and their use
03/18/2010WO2010007382A8 Benzazepine derivatives and their use as hstamine h3 antagonists
03/18/2010WO2009137714A3 Forms of lapatinib ditosylate and processes for preparation thereof
03/18/2010WO2009121507A3 Substituted enaminothiocarbonyl compounds
03/18/2010US20100069638 Sulfonamide derivative having pgd2 receptor antagonistic activity
03/18/2010US20100069414 Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
03/18/2010US20100069379 Bicyclic androgen and progesterone receptor modulator compounds and methods
03/18/2010US20100069348 Novel compounds as cannabinoid receptor ligands
03/18/2010US20100069242 Novel-Crystalline Modification Of 4-(N-Methyl-Z-Chloro-5Pyridy Methylamino)-2, 5-Dihydrofuran-2-ON
03/18/2010US20100068695 Inhibitor for enzyme having two divalent metal ions as active center
03/18/2010CA2736988A1 Compounds for the treatment of hepatitis c
1 ... 132 133 134 135 136 137 138 139 140 141 142 143 144 145 146 147 148 149 150 151 152 ... 694